Search…
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Search...
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Home
>
Latest
Lates News
16/05/2025
Royal Bank of Canada: Maintains Aardvark Therapeutics (AARD.US) rating from Outperform to Market Outperform, target price adjusted from $21.00 to $20.00.
Latest
6 m ago
William Blair: Downgrade NV5 Global (NVEE.US) rating from outperform to market perform.
7 m ago
China Natural Resources (CHNR.US): The 2024 FY financial report achieved earnings per share of -0.04 US dollars.
8 m ago
The U.S. two-year Treasury bond yield fell by 10 basis points to 3.95%.
8 m ago
CEA Industries (CEAD.US): The Q1 financial report for 2025 achieved a revenue of $713,460, with a previous value of $234,510; earnings per share were -$1.33, compared to the previous value of -$1.34.
8 m ago
1847 Holdings (EFSH.US): The Q1 revenue in 2025 reached $10.83 million, compared to $2.084 million in the previous period; the earnings per share were -$0.01, compared to -$854.10 in the previous period.
See all latest